-
Nations commit to get nature goals back on track
-
OKC's Holmgren to miss at least eight weeks as Thunder injury woes deepen
-
US oil companies aim to squeeze more out of refineries
-
'Not very smart' - Verstappen slams Red Bull stable-mate after clash
-
Leclerc quickest in Mexico GP practice
-
Trump admin approves potential Patriot missiles sale to Ukraine
-
Polish riot police deployed as deposed court chief sets off crisis
-
Sun Goddess wins at Breeders' Cup, O'Brien leads Baffert
-
Young Canadians focus on mental health at key climate trial
-
Nations agree push to get nature goals on track
-
'Breath of fresh air' truce brings hope to Ukraine's ravaged Kherson
-
Leclerc shows practice pace as Antonelli prowls in Mexico
-
British king reflects on colonial atrocities in Guyana
-
Trump, Milei under pressure to explain Bolsonaro flight from Brazil
-
Nations agree crucial texts in overtime at UN nature summit
-
Hakimi bags hat-trick as Paris Saint-Germain rip Le Havre to pieces
-
NBA Trail Blazers lose guard Morant for four weeks
-
Polish riot police deployed after court chief suspended
-
UN nature summit in extra time as nations grapple for deal
-
Emery's focus fully on Fulham despite Barcelona tie
-
Complaints upheld against Swiss TV commentary on Israeli bobsleigher
-
Reigning champs chase history in New York Marathon
-
Tielemans glad Man Utd sticking with Carrick
-
Monaco taken off global money-laundering 'grey list'
-
Scottish police probe Andrew, Epstein stay at royal castle: UK media
-
Canada, EU launch new alliance with deals on Ukraine, minerals, AI
-
Medvedev into Vienna semis and books ATP Finals place
-
Tears, fear, anger: relatives of Spain train crash dead await fate
-
UN nature talks in extra time as nations struggle to reach deal
-
Spurs get Maddison boost ahead of Palace clash
-
Meta settles, leaving Snap sole defendant in new social media trial
-
French authorities fear new street violence at Halloween protests
-
Chelsea manager Alonso dismisses talk of Estevao loan deal
-
Rickelton, Mulder centuries lift South Africa's chances in Test decider
-
Thousands of students, workers hold peaceful protests in Italy
-
Maresca adamant Donnarumma can be dropped but first name selected
-
Iraola glad to raise Liverpool fans' hopes but says hard work ahead
-
EU and Canada to 'withstand shocks together' with new alliance
-
Pope Leo makes history with US midterm vote
-
Flick praises Yamal 'mentality' after missing out on Ballon d'Or
-
Arsenal boss Arteta fires 'Disneyland' warning at Dowman after Fleetwood red card
-
Binance heist: How were cryptocurrency billions stolen?
-
Russia's ice hockey stars come in from the cold after CAS ruling
-
France boards up ahead of Halloween protests
-
Wall Street tech rout deepens on doubts over AI spending
-
Is Bukele's troop deployment in Haiti just a rescue mission?
-
'Life in the old dog': German economy grows more than expected
-
Relatives' anguish grows as Spain identifies train crash dead
-
England great Anderson asks what's 'wrong with me?' after Lancashire exit
-
Italy inflation surges to 5.4% as economy stalls
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
O.Schlaepfer--VB